These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31081416)

  • 1.
    Vidović K; Bogdanić N; Balen Topić M
    Infect Dis (Lond); 2019 Jul; 51(7):554-557. PubMed ID: 31081416
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential impact of removing metronidazole from treatment armamentarium of mild acute
    Zilberman-Itskovich S; Youngster I; Lazarovitch T; Bondarenco M; Toledano L; Kachlon Y; Mengesha B; Strul N; Zaidenstein R; Marchaim D
    Future Microbiol; 2019 Nov; 14():1489-1495. PubMed ID: 31913060
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
    Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
    J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "High frequency of nonadherence to Clostridium difficile treatment guidelines".
    Froom P
    South Med J; 2014 Sep; 107(9):600-1. PubMed ID: 25188628
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study.
    Najjar-Debbiny R; Bazazhina A; Schwartz N; Shaked P; Saliba W; Weber G
    Infection; 2022 Aug; 50(4):973-980. PubMed ID: 35192148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
    Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin Versus Metronidazole for Nonsevere
    Sarna KV; Gross AE
    Ann Pharmacother; 2019 Aug; 53(8):845-852. PubMed ID: 30734567
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
    Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
    J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Metronidazole and Vancomycin Utilization for Nonsevere Clostridioides difficile Infection Among Institutions Caring for Children.
    Stultz JS; Hopp J; Orndahl CM; Omecene NE; Pakyz AL
    Pediatr Infect Dis J; 2021 Jul; 40(7):634-636. PubMed ID: 33657601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
    Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP
    J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
    Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
    Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rise and Fall of Metronidazole for Clostridium difficile Infection.
    Chahine EB
    Ann Pharmacother; 2018 Jun; 52(6):600-602. PubMed ID: 29424238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
    Vega AD; Heil EL; Blackman AL; Banoub M; Kristie Johnson J; Leekha S; Claeys KC
    Pharmacotherapy; 2020 May; 40(5):398-407. PubMed ID: 32246501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018.
    Adelman MW; Goodenough D; Sefton S; Mackey C; Thomas S; Fridkin SK; Woodworth MH
    Anaerobe; 2021 Aug; 70():102364. PubMed ID: 33862203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
    Wilcox MH; Howe R
    J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.